NCT06179888 2026-03-18
Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple Myeloma
National Cancer Institute (NCI)
Phase 2 Recruiting
National Cancer Institute (NCI)
Institut Bergonié
Mayo Clinic
Mayo Clinic
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
University of Colorado, Denver
AIDS Malignancy Consortium
Roswell Park Cancer Institute